Chance Pharmaceuticals
PrivateLast Round
VC Round
Mar 17, 2025
Total Funding Raised
$30M
Company Overview
Chance Pharmaceuticals is a clinical-stage biotechnology company based in Hangzhou, China, that was founded in 2015. The company specializes in the discovery, development, and commercialization of inhalation therapies for debilitating diseases such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary arterial hypertension, and central nervous system disorders. Chance Pharmaceuticals utilizes two core technology platforms, milling/mixing and spray drying, to create innovative dry powder inhalation (DPI) therapies. The company is privately held and venture capital-backed, having completed multiple funding rounds to advance its product pipeline through clinical trials. It operates production facilities compliant with FDA and EMA quality standards.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical Devices, Pharma Supply Chain
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chance Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Chance Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 17, 2025 | ||||
| Series C Extension | Jan 4, 2022 | ||||
| Series C | Oct 11, 2021 |
Chance Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Merchants Securities | Series C |
| Lapam Capital | Series C |
| Shenzhen Dachen Caizhi Venture Capital Management | Series C Extension |
| 北京启航创业投资管理有限公司 | VC Round |
| HEDA Ventures | VC Round |
Chance Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Chance Pharmaceuticals's valuation, stock price, and market status.
